Vertebral fracture is associated with myocardial infarction in incident hemodialysis patients:​ a Korean nationwide population-based study

Kwon, Y. E.; Choi, H. Y.; Oh, H. J.; Ahn, S. Y.; Ryu, D.-R.; Kwon, Y. J.

Affiliations

¹Department of Internal Medicine, Hanyang University College of Medicine, Myongji Hospital, Goyang-si, South Korea

²The Korean Society of Nephrology, Seoul, South Korea

³Ewha Institute of Convergence Medicine and Research Institute for Human Health Information, Ewha Womans University, Seoul, South Korea

⁴Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea

⁵Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, South Korea

Abstract and keywords

Summary: Chronic kidney disease (CKD)-mineral and bone disorder suggests that fragile bone and vascular disorder might be connected closely in CKD patients. In this study, fracture event was significantly associated with myocardial infarction (MI) in end-stage renal disease patients on hemodialysis (HD), especially for vertebral fractures.

Introduction: CKD-mineral and bone disorder is characterized by biochemical abnormalities, bone disorders, and vascular calcification. We aimed to verify the association between fracture and MI in CKD patients.

Methods: Records for incident CKD stage 3 to 5 patients and patients who initiated HD between July 2014 and June 2018 were retrieved from the Korean Health Insurance Review & Assessment Service Database. Fractures were defined using diagnostic codes and were classified into vertebral, femoral, and other site fractures. MI was defined using a combination of MI diagnostic codes and related procedure codes. Multiple logistic regressions and 1:1 propensity score matching analysis were conducted.

Results: A total of 38,935 patients (HD, 11,379; pre-dialysis CKD, 27,556) were included in this study. A total of 5,057 (13.0%) patients experienced fracture, and 1,431 (3.7%) patients had MI. Multiple logistic regression analysis showed that fracture was significantly associated with MI in the HD group (odds ratio (OR) 1.34, P = 0.024), but not in the pre-dialysis CKD group (OR 1.04, P = 0.701). After propensity score matching for age, gender, and diabetes mellitus between patients with and without fracture, fracture still significantly correlated with MI in HD patients (OR 1.47, P = 0.034) but not in patients with pre-dialysis CKD (OR 1.04, P = 0.751). Subgroup analysis by fracture site found that vertebral fracture was associated with MI in HD patients (OR 2.11, P = 0.024), but femoral or other site fractures were not.

Conclusion: In HD patients, fracture was significantly associated with MI, especially for vertebral fractures patients.

Keywords: Fracture; Hemodialysis; Myocardial infarction; Vertebral

Links

DOI: 10.1007/s00198-020-05423-y

PubMed: 32394062

WoS: 000531918500001

History

Received: 2019-11-21

Accepted: 2020-04-14

Online: 2020-05-11

Cited Works (4)

Year	Entry
2020	Lv F, Cai X, Yang W, Gao L, Chen L, Wu J, Ji L. Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: systematic review and meta-analysis. Bone. January 2020;130:115121.
2020	Lau EMC, Dinavahi R, Woo YC, Wu C-H, Guan J, Maddox J, Tolman C, Yang W, Shin CS. Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study. Osteoporos Int. April 2020;31(4):677-685.
2009	KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD). Kidney Int. August 2009;76(suppl 113):S1-S130.
2000	Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. July 2000;58(1):396-399.